Infirst reports positive top-line data from Phase III FLARE study of BC1054 to treat knee pain

UK-based Infirst Healthcare has reported positive top-line data from its Phase III IFH-2014-002 FLARE study of BC1054 to treat knee pain.

Source: Drug Development Technology - October 4, 2016 Category: Pharmaceuticals Source Type: news